Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Class Ia antiarrhythmic agent (substance) |
Is a |
True |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Class Ib antiarrhythmic agent (substance) |
Is a |
True |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Class Ic antiarrhythmic agent |
Is a |
True |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Moracizine |
Is a |
True |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Class I antiarrhythmic adverse reaction |
Causative agent (attribute) |
True |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Moracizine adverse reaction |
Causative agent (attribute) |
False |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to class I antiarrhythmic agent |
Causative agent (attribute) |
False |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to moracizine |
Causative agent (attribute) |
False |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Class I antiarrhythmic overdose |
Causative agent (attribute) |
True |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Moracizine 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely moracizine 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing moracizine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing moricizine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pharmacological challenge with Class l antiarrhythmic drug to unmask ST elevation (procedure) |
Using substance (attribute) |
False |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pharmacological challenge with Class l antiarrhythmic drug to unmask ST elevation (procedure) |
Using substance (attribute) |
True |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to class I antiarrhythmic agent |
Causative agent (attribute) |
False |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vernakalant |
Is a |
True |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Class I antiarrhythmic drug (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Moricizine hydrochloride |
Is a |
True |
Class I antiarrhythmic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|